OrthoAccel Technologies, Inc. announced this week that following a successful limited market release of AcceleDent last October it will be initiating a full-market release throughout the United Kingdom this coming September. Availability of AcceleDent, which is a regulated medical device and only available to dental professionals to prescribe to their patients, will be featured at the British Orthodontic Conference (BOC) next month in Brighton.
AcceleDent is a simple, removable dental device that patients place in the mouth for twenty minutes daily. It produces a gentle vibrational force which enhances the pressure applied by braces. AcceleDent has been clinically proven to safely speed up orthodontic tooth movement. The product is hands-free and allows the user flexibility to carry out most routine tasks during use.
The AcceleDent System is currently being sold to select orthodontic specialists in the United Kingdom, where it was introduced last year through a limited market release program. Approximately twenty orthodontic specialists participated in the evaluation program, which the Company used as an important learning experience. Mike Kaufman, VP Marketing and Business Development at OrthoAccel, commented, "The controlled UK introduction has provided an invaluable opportunity to experience customer purchasing preferences and marketing approaches to incorporate AcceleDent into the orthodontic treatment plan. The ability to intimately dialogue with these early adopter orthodontists has yielded several product refinements, which have already been implemented. These orthodontists are very encouraged by the results they are seeing and in general have been able to move through the treatment plan at a quicker pace."
Patients have reported using the device while engaged in a variety of activities, including homework, watching television and reading. The vibrating force has been described as "very light," and one patient remarked, "The pulsing feels like a gentle massage for my teeth and gums – and I look forward to it every evening."
And it seems that every patient has a unique story driving the desire to complete treatment and reach the final result of a beautiful smile as quickly as possible. "I definitely want to finish treatment before I go to university, and plan to travel for the second six months of my gap year. Clear braces mean I don't feel nearly so self conscious and AcceleDent means I can expect to finish all my treatment by the end of this year - which is really great," remarked James, a 17 year old patient under the care of Dr Sharon Orton-Gibbs at Walpole Specialists, Surbiton.
The Company has reported plans to host a gathering at the BOC in Brighton next month for the group of early-user orthodontic specialists, in order to review patient case progress and other insights. OrthoAccel is anticipating the conclusion of another US clinical trial at the UT Health Science Center in San Antonio with a target completion date later in 2010.
OrthoAccel Technologies, Inc.